BME postdoctoral researcher Guanping Yu wins KTEF grant for research on Stargardt disease

Guanping Yu, a postdoctoral researcher in the lab of Zheng-Rong Lu, the M. Frank and Margaret Domiter Rudy Professor of Biomedical Engineering, has been awarded a $60,000 Career Starter Research Grant from the Knights Templar Eye Foundation (KTEF) to explore treatments for Stargardt disease.
Stargardt disease is the most common form of juvenile retinal macular degeneration and affects one in 10,000 people in the United States. Currently, there is no cure for the disease and little that can be done to prevent, halt or slow the process of vision loss.
Yu will use the KTEF grant to explore new therapeutics that can decrease the accumulation of a compound called all-trans-retinal (atRAL), which is a key factor in the onset of Stargardt disease.
Incorporated in 1956, the KTEF is a charity sponsored by the Grand Encampment of Knights Templar that supports research into the prevention and cure of potentially blinding disease in infants and children.